Haowei Biomed
浩微生物
Haowei Biomed
Biotech/Healthcare
Suzhou Haowei Biomedical Technology Co., Ltd. is a technology company developing vascular interventional embolization products based on its core drug-device combination technology.
Latest round: Series A (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-11-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.